(Total Views: 282)
Posted On: 02/13/2023 10:45:48 AM
Post# of 62

$MBRX News Article - Moleculin Announces Final Topline Data from Successful European Phase 1 Trial Evaluating Annamycin as Single Agent Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/mole...20147.html


My Twitter: WhyteStocks